AM3102

AM3102

CAT N°: 13452

Oleoyl ethanolamide (OEA) is an endogenous agonist for proliferator-activated receptor ? (PPAR?) that suppresses food intake, promotes lipolysis, and reduces weight gain in rodents. The biological effects of OEA are terminated by fatty-acid amide hydrolase and N-acylethanolamine-hydrolyzing acid amidase. AM3102 is an OEA analog that stimulates PPAR? transcriptional activity with an EC50 value of 100 nM and prolongs feeding latency in rodents with an ED50 value of 2.4 mg/kg.{17364} It is resistant to enzymatic hydrolysis and is as potent as OEA in enhancing transcriptional activity of PPAR? and reducing food intake in free-feeding rats.{17364,15762} AM3102 demonstrates weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors with Ki values of 33 and 26 µM, respectively.{7422}

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • N-[(1R)-2-hydroxy-1-methylethyl-9Z-octadecenamide
  • Correlated keywords
    • OEA PPARs PPAR? KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic
  • Product Overview:
    Oleoyl ethanolamide (OEA) is an endogenous agonist for proliferator-activated receptor ? (PPAR?) that suppresses food intake, promotes lipolysis, and reduces weight gain in rodents. The biological effects of OEA are terminated by fatty-acid amide hydrolase and N-acylethanolamine-hydrolyzing acid amidase. AM3102 is an OEA analog that stimulates PPAR? transcriptional activity with an EC50 value of 100 nM and prolongs feeding latency in rodents with an ED50 value of 2.4 mg/kg.{17364} It is resistant to enzymatic hydrolysis and is as potent as OEA in enhancing transcriptional activity of PPAR? and reducing food intake in free-feeding rats.{17364,15762} AM3102 demonstrates weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors with Ki values of 33 and 26 µM, respectively.{7422}

We also advise you